Cytosorbents CorporationCTSONASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Latest
0.00%
↓ 100% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive growthDecelerating
Average
126.34%
Historical baseline
PeriodValue
20250.00%
2024-100.00%
20231271.11%
2022-92.74%
202122.12%
202028.79%
20196.96%
201848.30%
201725.59%
201653.31%